OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
002430$28.6259

Hangzhou Oxygen Plant Group Co Ltd

Commodity ChemicalsVerified

Hangzhou Oxygen Plant Group Co Ltd has a market capitalization of CNY 28.0 billion and a price-to-earnings ratio of 29.51, which is above the median for the Commodity Chemicals industry. The company's liquidity position is rated as medium, with a current ratio of 1.34 and a negative net cash position after subtracting total debt. Free cash flow is negative at CNY -99.88 million, indicating that capital expenditures are outpacing operating cash flow. Profitability metrics show a return on equity of 9.6% and a return on assets of 3.85%, both below the industry median. The company's gross margin is 20.7%, and operating margin is 9.3%, which are in line with the industry average. However, the net margin of 6.3% is slightly below the median for the sector. The company's revenue is concentrated in a few key markets, with the majority of sales coming from domestic operations in China. There is no significant international revenue exposure reported in the latest financial data. The company operates in a single business segment, which increases its exposure to sector-specific risks. Looking ahead, the company is expected to see a modest increase in revenue, with analysts forecasting a mean price target of CNY 33.29, representing a 16.3% upside from the current market price. The mean recommendation of 1.50 suggests a generally positive outlook among analysts. However, the company's capital expenditures are expected to remain high, which could impact near-term profitability. The company faces moderate liquidity risk due to its negative net cash position and a debt-to-equity ratio of 0.75. While the debt level is manageable, the negative free cash flow indicates that the company is not generating sufficient cash to cover its capital expenditures. The risk of dilution is currently low, but the company has not disclosed any specific plans for share buybacks or dividends. Recent filings and transcripts indicate that the company is focused on expanding its production capacity to meet growing demand in the industrial gases market. The company has also emphasized its commitment to environmental sustainability and operational efficiency. No major regulatory or geopolitical risks have been identified in the latest disclosures.

30-day price · 002430-1.08 (-3.8%)
Low$27.30High$33.43Close$27.32As of22 May, 00:00 UTC
Profile
CompanyHangzhou Oxygen Plant Group Co Ltd
Ticker002430.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Hangzhou Oxygen Plant Group Co Ltd produces and distributes industrial gases, primarily oxygen, nitrogen, and argon, serving sectors such as metallurgy, healthcare, and electronics.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with 92% confidence.

Hangzhou Oxygen Plant Group Co Ltd has a market capitalization of CNY 28.0 billion and a price-to-earnings ratio of 29.51, which is above the median for the Commodity Chemicals industry. The company's liquidity position is rated as medium, with a current ratio of 1.34 and a negative net cash position after subtracting total debt. Free cash flow is negative at CNY -99.88 million, indicating that capital expenditures are outpacing operating cash flow. Profitability metrics show a return on equity of 9.6% and a return on assets of 3.85%, both below the industry median. The company's gross margin is 20.7%, and operating margin is 9.3%, which are in line with the industry average. However, the net margin of 6.3% is slightly below the median for the sector. The company's revenue is concentrated in a few key markets, with the majority of sales coming from domestic operations in China. There is no significant international revenue exposure reported in the latest financial data. The company operates in a single business segment, which increases its exposure to sector-specific risks. Looking ahead, the company is expected to see a modest increase in revenue, with analysts forecasting a mean price target of CNY 33.29, representing a 16.3% upside from the current market price. The mean recommendation of 1.50 suggests a generally positive outlook among analysts. However, the company's capital expenditures are expected to remain high, which could impact near-term profitability. The company faces moderate liquidity risk due to its negative net cash position and a debt-to-equity ratio of 0.75. While the debt level is manageable, the negative free cash flow indicates that the company is not generating sufficient cash to cover its capital expenditures. The risk of dilution is currently low, but the company has not disclosed any specific plans for share buybacks or dividends. Recent filings and transcripts indicate that the company is focused on expanding its production capacity to meet growing demand in the industrial gases market. The company has also emphasized its commitment to environmental sustainability and operational efficiency. No major regulatory or geopolitical risks have been identified in the latest disclosures.
Key takeaways
  • The company's price-to-earnings ratio of 29.51 is above the industry median, suggesting it may be overvalued relative to its earnings.
  • Return on equity of 9.6% is below the industry median, indicating subpar profitability.
  • The company's liquidity position is medium, with a current ratio of 1.34 and a negative net cash position.
  • Analysts have a generally positive outlook, with a mean price target of CNY 33.29 and a mean recommendation of 1.50.
  • The company's capital expenditures are expected to remain high, which could impact near-term profitability.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$15.08B
Gross profit$3.13B
Operating income$1.41B
Net income$948.9M
R&D
SG&A
D&A
SBC
Operating cash flow$2.22B
CapEx-$1.70B
Free cash flow-$99.9M
Total assets$24.64B
Total liabilities$14.75B
Total equity$9.88B
Cash & equivalents
Long-term debt$7.37B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$15.08B$1.40B$948.9M-$99.9M
FY-1$13.72B$1.25B$922.4M-$1.96B
FY-2$13.31B$1.64B$1.22B-$2.03B
FY-3$12.80B$1.63B$1.21B-$691.5M
FY-4$11.88B$1.60B$1.19B$474.2M
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$24.64B$9.88B
FY-1$24.07B$9.19B
FY-2$22.62B$8.90B
FY-3$19.24B$8.19B
FY-4$16.05B$7.32B
PeriodOCFCapExFCFSBC
FY0$2.22B-$1.70B-$99.9M
FY-1$2.25B-$2.96B-$1.96B
FY-2$2.46B-$3.08B-$2.03B
FY-3$1.44B-$2.02B-$691.5M
FY-4$1.26B-$1.09B$474.2M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$4.00B$369.8M$265.1M
FQ-1$3.65B$287.6M$191.6M
FQ-2$4.10B$413.6M$278.1M
FQ-3$3.76B$368.6M$253.1M
FQ-4$3.56B$334.9M$226.1M
FQ-5$3.36B$331.6M$247.1M
FQ-6$3.63B$302.4M$238.1M
FQ-7$3.42B$322.7M$233.2M
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$25.47B$10.17B$2.39B
FQ-1$24.64B$9.88B
FQ-2$25.51B$9.77B$2.52B
FQ-3$24.51B$9.48B
FQ-4$24.56B$9.50B$2.21B
FQ-5$24.07B$9.19B
FQ-6$23.99B$8.99B$2.97B
FQ-7$22.73B$8.75B
PeriodOCFCapExFCFSBC
FQ0$506.7M-$424.6M
FQ-1$2.22B-$1.70B
FQ-2$1.95B-$1.67B
FQ-3$1.21B-$1.14B
FQ-4$424.0M-$489.7M
FQ-5$2.25B-$2.96B
FQ-6$811.1M-$1.74B
FQ-7$614.0M-$1.39B
Valuation
Market price$28.62
Market cap$28.00B
Enterprise value$35.37B
P/E29.5
Reported non-GAAP P/E
EV/Revenue2.4
EV/Op income25.1
EV/OCF15.9
P/B2.8
P/Tangible book2.8
Tangible book$9.88B
Net cash-$7.37B
Current ratio1.3
Debt/Equity0.8
ROA3.9%
ROE9.6%
Cash conversion2.3%
CapEx/Revenue-11.2%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric002430Activity
Op margin9.3%0.4% medp25 -8.0% · p75 16.0%above median
Net margin6.3%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin20.7%20.8% medp25 14.9% · p75 24.0%below median
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-11.2%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity75.0%59.0% medp25 54.9% · p75 72.9%top quartile
Observations
IR observations
Mean price target33.29 CNY
Median price target32.00 CNY
High price target38.76 CNY
Low price target30.00 CNY
Mean recommendation1.50 (1=strong buy, 5=strong sell)
Strong-buy count4.00
Buy count4.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate1.25 CNY
Last actual EPS0.96 CNY
Source: analysis-pipeline (hybrid)Generated: 2026-05-20 01:29 UTCJob: 55c10772